Zobrazeno 1 - 10
of 50
pro vyhledávání: '"M, Pastor Borgoñón"'
Autor:
Elisabeth Pérez-Ruiz, A. Lozano, S. Vázquez Fernández, Raquel Seijas-Tamayo, Ricard Mesia, Miren Taberna, Juan J. Cruz-Hernández, E. del Barco Morillo, R. González Sarmiento, J.C. Adansa Klain, M. Pastor Borgoñón, Javier Fernández-Mateos
Publikováno v:
Oral Oncology. 63:38-43
ObjectivesTo examine the relationship between polymorphisms of the epidermal growth factor receptor (EGFR) pathway and toxicity in head and neck squamous cell carcinoma (HNSCC) patients treated with cetuximab.Material and methodsMulticenter, retrospe
Autor:
Marina Pollán, C. Salvador Coloma, Raquel Seijas-Tamayo, Javier Martinez-Trufero, Elisabeth Pérez-Ruiz, A. Rueda Domínguez, S. Vazquez Estevez, Ricard Mesia, T. Bonfill Abella, Juan J. Cruz-Hernández, S. Vázquez Fernández, Miren Taberna, J.C. Adansa Klain, M. Pastor Borgoñón, E. del Barco Morillo, Javier Fernández-Mateos
Publikováno v:
Europe PubMed Central
Head and neck cancer is a highly heterogeneous disease comprising a large number of tumors located in the cervicofacial area. This study aimed to determine the epidemiological characteristics of squamous-cell carcinomas of the head and neck in the Sp
Autor:
Antonio Rueda, B. Cirauqui Cirauqui, A. Carral Maseda, J. J. Lambea Sorrosal, J.J. Cruz Hernandez, V. Arrazubi Arrula, L. C. Iglesias Docampo, Y. Escobar, M. Pastor Borgoñón, N. Baste Rotllan
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Clinical & Translational Oncology
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Consejería de Sanidad de la Comunidad de Madrid
Clinical & Translational Oncology
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Head and neck cancer (HNC) is defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c789eb5c1a24b3c6ce509594a6e4504c
https://hdl.handle.net/20.500.12530/29659
https://hdl.handle.net/20.500.12530/29659
Autor:
Luciano Iglesias, J. Martinez Trufero, J. Rubió Casadevall, A. Lopez Pousa, S. Vázquez, R. Mesia Nin, M. E. Ortega Izquierdo, M. Pastor Borgoñón, A. Lozano, J.M. Ponce, B. Cirauqui Cirauqui, J.J. Lambea Sorrosal, M. Taberna Sanz, Juan J. Cruz-Hernández, E. del Barco Morillo, P. Perez Segura
Publikováno v:
Annals of Oncology. 30:v458
Background Patients (pts) not candidates to platinum-based therapies have limited therapeutic options. The addition of P to PTX followed by RT + P may be an alternative to platinum-based therapy. This study aimed to evaluate the activity of P + PTX a
Autor:
M. Pastor Borgoñón, S. Ochenduszko, J. Lavernia, A.J. Cunquero Tomas, S. Blasco, A. Berrocal Jaime, S. Sandiego, J. Caballero Daroqui, J. García Sánchez, Gema Bruixola, A. Iranzo
Publikováno v:
Annals of Oncology. 29:viii383-viii384
Autor:
M. Pastor Borgoñón, Cristina Quero, Ramón García-Sanz, Mariano Provencio, M. Casanova, Antonio Salar, J. Labrador, Antonio Rueda
Publikováno v:
Annals of Oncology. 25:iv330
Aim: Relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL) after autologous stem cell transplantation (ASCT) remains a challenge. For these patients (pts) treatments with different mechanism of action rather than classical chemotherapy (CHT)
Autor:
C. García-Girón, Ricardo Hitt, Javier Martinez-Trufero, C. Almodóvar Alvarez, Joaquin Casal Rubio, E. del Barco Morillo, E. Galve Calvo, M. Taberna-Sanz, Jaume Grau, J. Martínez-Galán, J.C. Adansa Klain, M. Pastor Borgoñón, Régulo López, Silvia Vazquez, R. Bastus, Beatriz Cirauqui, Alfonso Berrocal, J.J. Cruz Hernandez, Ricard Mesia, O. Juan-Vidal
Publikováno v:
Annals of Oncology. 25:iv355
Background: ICT with taxanes regimens has been demonstrate increase overall survival (OS) in the recent metaanalysis (Blanchard JCO 2013) in patients (pts) with LAHNC. However CRTP or RTCx hasnt be compared as consolidation treatment. This randomized
Autor:
J A, Todolí Parra, C, Campo López, A, Segura Huerta, R, Alonso Estellés, E, Saro Pérez, A, Torrego Giménez, A, Santaballa Bertrán, M, Pastor Borgoñón, J R, Calabuig Alborch
Publikováno v:
Revista clinica espanola. 199(11)
The diagnosis of second malignancies in patients with multiple myeloma is uncommon. It is debatable whether this tumor is in itself a risk factor for the incidence of second malignancies. Etiopathogenic factors which might account for this associatio
Publikováno v:
Revista clinica espanola. 198(11)
Publikováno v:
Revista clinica espanola. 197(11)
Multiple primary neoplasms are increasing in clinical practice, which is mainly due to the longer survival of cancer patients. Radiotherapy at an early stage of Hodgkin disease or lymphoma is well known to be associated with the future occurrence of